Skip to search formSkip to main contentSkip to account menu

epidermal growth factor receptor VIII

Known as: EGFRvIII 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
A deletion variant of epidermal growth factor receptor (EGFRvIII) is a known driver mutation in a subset of primary and secondary… 
Highly Cited
2017
Highly Cited
2017
Purpose: Approximately 40% of all glioblastomas have amplified the EGFR gene, and about half of these tumors express the EGFRvIII… 
Highly Cited
2014
Highly Cited
2014
BACKGROUND As a commonly mutated form of the epidermal growth factor receptor, EGFRvIII strongly promotes glioblastoma (GBM… 
Highly Cited
2013
Highly Cited
2011
Highly Cited
2011
The epidermal growth factor receptor variant III (EGFRvIII) is associated with increased proliferation of glioma cells. However… 
Review
2009
Review
2009
Highly Cited
2007
Highly Cited
2007
EGFRvIII is a mutant variant of the epidermal growth factor receptor (EGFR) found exclusively in various cancer types. EGFRvIII… 
Highly Cited
2006
Highly Cited
2006
Purpose: Epidermal growth factor receptor (EGFR) is overexpressed in head and neck squamous cell carcinoma (HNSCC) where… 
Highly Cited
2005
Highly Cited
2005
In colorectal cancer, epidermal growth factor receptor (EGFR) expression is reported in 8-100% of the cases examined and there… 
Highly Cited
1997
Highly Cited
1997
The type-III deletion variant of the epidermal growth factor receptor (EGFRvIII) is frequently found in glioblastomas and other…